These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 39084211)

  • 41. Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.
    Shen T; Vogel JW; Duda J; Phillips JS; Cook PA; Gee J; Elman L; Quinn C; Amado DA; Baer M; Massimo L; Grossman M; Irwin DJ; McMillan CT
    Transl Neurodegener; 2023 Dec; 12(1):57. PubMed ID: 38062485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
    Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
    Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identifying an Optimal Neuroinflammation Treatment Using a Nanoligomer Discovery Engine.
    Sharma S; Borski C; Hanson J; Garcia MA; Link CD; Hoeffer C; Chatterjee A; Nagpal P
    ACS Chem Neurosci; 2022 Dec; 13(23):3247-3256. PubMed ID: 36410860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides.
    Singh K; Gupta JK; Kumar S; Soni U
    Curr Protein Pept Sci; 2024; 25(7):507-526. PubMed ID: 38561605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Weishaupt JH; Hyman T; Dikic I
    Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Bright F; Chan G; van Hummel A; Ittner LM; Ke YD
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Granulin loss of function in human mature brain organoids implicates astrocytes in TDP-43 pathology.
    de Majo M; Koontz M; Marsan E; Salinas N; Ramsey A; Kuo YM; Seo K; Li H; Dräger N; Leng K; Gonzales SL; Kurnellas M; Miyaoka Y; Klim JR; Kampmann M; Ward ME; Huang EJ; Ullian EM
    Stem Cell Reports; 2023 Mar; 18(3):706-719. PubMed ID: 36827976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease.
    Wilke C; Gillardon F; Deuschle C; Dubois E; Hobert MA; Müller vom Hagen J; Krüger S; Biskup S; Blauwendraat C; Hruscha M; Kaeser SA; Heutink P; Maetzler W; Synofzik M
    Curr Alzheimer Res; 2016; 13(6):654-62. PubMed ID: 26971930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).
    García-García R; Martín-Herrero L; Blanca-Pariente L; Pérez-Cabello J; Roodveldt C
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
    Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
    Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
    Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
    Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stimulating VAPB-PTPIP51 ER-mitochondria tethering corrects FTD/ALS mutant TDP43 linked Ca
    Markovinovic A; Martín-Guerrero SM; Mórotz GM; Salam S; Gomez-Suaga P; Paillusson S; Greig J; Lee Y; Mitchell JC; Noble W; Miller CCJ
    Acta Neuropathol Commun; 2024 Feb; 12(1):32. PubMed ID: 38395965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Lastres-Becker I; de Lago E; Martínez A; Fernández-Ruiz J
    Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frontotemporal dementia-amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1-q12.2: genetic, clinical and neuropathological analysis.
    Dobson-Stone C; Luty AA; Thompson EM; Blumbergs P; Brooks WS; Short CL; Field CD; Panegyres PK; Hecker J; Solski JA; Blair IP; Fullerton JM; Halliday GM; Schofield PR; Kwok JB
    Acta Neuropathol; 2013 Apr; 125(4):523-33. PubMed ID: 23338750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases.
    Hart de Ruyter FJ; Evers MJAP; Morrema THJ; Dijkstra AA; den Haan J; Twisk JWR; de Boer JF; Scheltens P; Bouwman FH; Verbraak FD; Rozemuller AJ; Hoozemans JJM
    Acta Neuropathol; 2024 Aug; 148(1):24. PubMed ID: 39160362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modeling Neurodegenerative Microenvironment Using Cortical Organoids Derived from Human Stem Cells.
    Yan Y; Song L; Bejoy J; Zhao J; Kanekiyo T; Bu G; Zhou Y; Li Y
    Tissue Eng Part A; 2018 Jul; 24(13-14):1125-1137. PubMed ID: 29361890
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclin F, Neurodegeneration, and the Pathogenesis of ALS/FTD.
    Rayner SL; Hogan A; Davidson JM; Cheng F; Luu L; Morsch M; Blair I; Chung R; Lee A
    Neuroscientist; 2024 Apr; 30(2):214-228. PubMed ID: 36062310
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations.
    Le NT; Chang L; Kovlyagina I; Georgiou P; Safren N; Braunstein KE; Kvarta MD; Van Dyke AM; LeGates TA; Philips T; Morrison BM; Thompson SM; Puche AC; Gould TD; Rothstein JD; Wong PC; Monteiro MJ
    Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7580-E7589. PubMed ID: 27834214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
    Vanden Broeck L; Callaerts P; Dermaut B
    Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.